Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FATHG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,013
Award facts
- Contract value 100% obligated
- $3,012.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $3,012.90 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 1, 2025, for NUCALA 100 mg/ml auto-injectors. The contract, which carries no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the vendor's location in Park Ridge, Illinois. This delivery order represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026.
The DLA's pharmaceutical supply program, through which this delivery order was issued, supports medical supply needs across Department of Defense healthcare facilities nationwide. NUCALA (mepolizumab) is a biologic pharmaceutical used for asthma and eosinophilic conditions, and this procurement reflects the agency's ongoing demand for specialized pharmaceutical products to maintain military health system inventories. DMS Pharmaceutical Group's status as an established federal pharmaceutical supplier with consistent contract awards demonstrates its capability to fulfill the DLA's requirements for branded medications, biologics, and medical consumables across its extensive product portfolio.
Quick answers
Who was awarded contract SPE2DB25FATHG?
SPE2DB25FATHG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FATHG worth?
The government has obligated $3,013 on SPE2DB25FATHG.
Is contract SPE2DB25FATHG an order under another contract?
Yes. SPE2DB25FATHG is a delivery order under SPE2DB24D9228, an indefinite delivery contract.
Was contract SPE2DB25FATHG competed?
The extent of competition for SPE2DB25FATHG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award